🔎 Trials Near Me

Hjem › Overvægt › Texas › Dallas

Overvægt kliniske forsøg i Dallas, TX

30 studier for Overvægt søger deltagere på steder i og omkring Dallas (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

RekruttererFase 2
  • Velocity Clinical Research - Dallas /ID# 282734, Dallas
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07752979

Spinal Cord Injury Model Systems (SCIMS) - Education Module

Rekrutterer
  • Baylor Scott & White Institute for Research, Dallas
Alder 18 til 70 · Alle køn · Opdateret 30. sep. 2026 · NCT06003686

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

RekruttererFase 3
  • UT Southwestern Med Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07533175

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

RekruttererFase 3
  • North Texas Endocrine Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

RekruttererFase 3
  • UT Southwestern Med Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07668414

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

RekruttererFase 3
  • Velocity Clinical Res-Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07339423

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

RekruttererFase 3
  • UT Southwestern Medical Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07392190

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RekruttererFase 3
  • Thyroid Endocrinology and Diabetes, Dallas
  • Soltero Cardiovascular Research Center, Dallas
  • Zenos Clinical Research, Dallas
  • og 2 flere
Alder 45 til 99 · Alle køn · Opdateret 22. sep. 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas, Dallas
  • UT Southwestern Medical Center, Dallas
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07321886

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • FutureSearch Trials of Dallas, Dallas
Alder 18 til 75 · Alle køn · Opdateret 22. sep. 2026 · NCT07589608

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

RekruttererFase 3
  • Cedar Health Research, LLC, Dallas
Alder 18 til 99 · Alle køn · Opdateret 16. sep. 2026 · NCT07037459

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

RekruttererFase 3
  • Velocity Clinical Research, Dallas
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

RekruttererFase 3
  • University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Alder 18 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07351045

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

RekruttererFase 3
  • Cedar Health Research, Dallas
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07770841

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

RekruttererFase 2
  • Velocity Clinical Research, Dallas, Dallas
  • FutureSearch Trials of Dallas, Dallas
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT06143956

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

RekruttererFase 2
  • Mercy Family Clinic, Dallas
  • Velocity Clinical Research, Dallas, Dallas
Alder 18 til 75 · Alle køn · Opdateret 8. sep. 2026 · NCT07215559

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

RekruttererFase 3
  • Cedar Health Research, LLC, Dallas
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684235

Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)

RekruttererTidlig fase 1Frivillige med god helbredstilstand velkomne
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 55 · Alle køn · Opdateret 3. sep. 2026 · NCT04838678

Effects of Obesity in the Aged

RekruttererFrivillige med god helbredstilstand velkomne
  • Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Alder 65 til 75 · Alle køn · Opdateret 2. sep. 2026 · NCT05028309

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

RekruttererFase 2
  • University of Texas, Southwestern, Dallas
Alder 7 til 25 · Alle køn · Opdateret 19. aug. 2026 · NCT05082519

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

RekruttererFase 3
  • Renal Disease Research Institute, Dallas
  • Texas Health Heart and Vascular Specialists, Dallas
  • Southwest Family Medicine_Dallas, Dallas
  • og 1 flere
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT07567001

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

RekruttererFase 3
  • Mercy Family Clinic, Dallas
Alder 18 og opefter · Alle køn · Opdateret 17. aug. 2026 · NCT07509307

A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia

RekruttererFase 2
  • Velocity Clinical Research Dallas, Dallas
Alder 18 til 80 · Alle køn · Opdateret 22. jul. 2026 · NCT07477704

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Rekrutterer
  • University of Texas Southwestern Medical Center, Dallas
Alder 18 til 65 · Alle køn · Opdateret 15. jul. 2026 · NCT06924177

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

RekruttererFrivillige med god helbredstilstand velkomne
  • UT Southwestern Medical Center, Dallas
Alder 55 til 90 · Alle køn · Opdateret 7. maj 2026 · NCT05723679

Leg Heating in Pregnant Women With Obesity

RekruttererFrivillige med god helbredstilstand velkomne
  • UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Alder 18 til 45 · Kvinder · Opdateret 17. apr. 2026 · NCT06932250

Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program

Rekrutterer
  • University of Texas Southwestern, Children's Health, Dallas
Alder 6 til 14 · Alle køn · Opdateret 30. mar. 2026 · NCT07342855

Healthy Living BEYOND Weight Study

RekruttererObservationsstudie
  • American Heart Association, Dallas
Alder 18 og opefter · Alle køn · Opdateret 6. aug. 2025 · NCT07075341

Overvægt forsøg i andre byer

Andre studier i Dallas

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.